Skip to main content
. Author manuscript; available in PMC: 2019 Feb 15.
Published in final edited form as: Cancer. 2017 Dec 6;124(4):807–815. doi: 10.1002/cncr.31124

Figure 1.

Figure 1

Figure 1

Figure 1

Figure 1

Figure 1

Figure 1

Proportion of poorly differentiated neuroendocrine carcinomas according to morphological subtype at major sites (1A), subsites including non-pulmonary, non-gastrointestinal (Other) sites (1B), gastrointestinal tract (1C).